NVO

Novo Nordisk A/SNYSEHealthcare

$36.98+1.36%OpenMarket Cap: $164.32B

As of 2026-04-06

Recent Analyst Ratings

Date	Firm	Action	Rating	Previous
2026-03-02	Goldman Sachs	—	Neutral	—
2026-02-24	JP Morgan	—	Neutral	—
2025-12-08	Argus Research	—	Hold	—
2025-11-28	Goldman Sachs	—	Buy	—
2025-11-25	BMO Capital	—	Market Perform	—
2025-11-24	HSBC	—	Hold	—
2025-10-14	BMO Capital	—	Market Perform	—
2025-10-02	HSBC	—	Buy	—
2025-09-29	Morgan Stanley	—	Underweight	—
2025-09-17	Berenberg	—	Buy	—

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Fri Dec 31	$21.54	$302.77B	8
Sun Dec 31	$23.40	$322.63B	7
Mon Dec 31	$25.76	$342.37B	6
Tue Dec 31	$28.13	$366.11B	6